---
title: "Cannabis Oil Market by Player, Region, Type, Application and  Forecast to 2025-2032"
datePublished: Fri Oct 03 2025 06:00:49 GMT+0000 (Coordinated Universal Time)
cuid: cmgafr51p000202jxh6elgjov
slug: cannabis-oil-market-by-player-region-type-application-and-forecast-to-2025-2032

---

# Cannabis Oil Market by Player, Region, Type, Application and  Forecast to 2025-2032

<p><strong>MARKET INSIGHTS</strong></p><p>
</p><p>Global cannabis oil market size was valued at USD 2.8 billion in 2024. The market is projected to grow from USD 3.4 billion in 2025 to USD 12.9 billion by 2032, exhibiting a CAGR of 21.7% during the forecast period.</p><div><b>Download FREE Sample of this Report @ 
            <a href="https://www.24chemicalresearch.com/download-sample/233189/cannabis-oil-market">
            https://www.24chemicalresearch.com/download-sample/233189/cannabis-oil-market</a></b></div><br><p>
</p><p>Cannabis oil is a concentrated extract derived from cannabis plants, primarily containing cannabinoids such as CBD and THC. These oils are categorized based on purity levels into food-grade and pharmaceutical-grade variants, with applications spanning nutraceuticals, food products, cosmetics, and medical treatments. The therapeutic potential of cannabinoids in pain management, anxiety relief, and neurological disorders is driving significant market interest.</p><p>
</p><p>The market expansion is fueled by progressive legalization across multiple regions, with North America currently dominating revenue share. However, Asia-Pacific shows the highest projected growth rate due to evolving regulatory frameworks. While medical applications currently lead adoption, the nutraceutical segment is gaining traction as consumer awareness about CBD's wellness benefits increases. Major players like Aurora Cannabis and Canopy Growth Corporation are expanding production capacities to meet the surging demand, particularly for THC-free formulations in regulated markets.</p><p>
<strong>MARKET DYNAMICS</strong></p><p>
<strong>MARKET DRIVERS</strong></p><p>
</p><p style="text-align:center"><strong>Expanding Legalization and Medical Applications to Accelerate Market Growth</strong></p><p>
</p><p>The global cannabis oil market is experiencing robust growth, driven primarily by increasing legalization across key markets. Over 50 countries have now legalized medical cannabis in some form, with several major economies permitting recreational use. This regulatory shift is creating unprecedented commercial opportunities as patient access improves and stigma diminishes. The medical cannabis sector, valued at over $20 billion in 2024, is projected to grow at nearly 20% CAGR through 2032 as clinical research validates therapeutic applications for conditions including chronic pain, epilepsy, and chemotherapy-induced nausea.</p><p>
</p><p style="text-align:center"><strong>Consumer Shift Towards Natural Wellness Products to Fuel Demand</strong></p><p>
</p><p>Wellness-focused consumers are increasingly choosing plant-derived alternatives over synthetic pharmaceuticals, driving cannabis oil adoption in nutraceutical and cosmetic applications. The global CBD wellness market is expected to surpass $50 billion by 2032 as consumers seek natural solutions for stress, sleep, and skincare. Premium product formulations combining cannabis oil with other functional ingredients are gaining traction, particularly in North America and Europe where consumer education about cannabinoid benefits is most advanced.</p><p>

</p><p><strong>â¤ Leading brands are investing heavily in clinical research to substantiate health claims, with over 300 ongoing clinical trials investigating cannabinoid therapeutics as of 2024.</strong></p><p>
</p><p>Furthermore, strategic partnerships between cannabis producers and established consumer brands are expanding distribution channels and product innovation. These collaborations are overcoming previous market fragmentation while accelerating mainstream acceptance.</p><p>
<strong>MARKET RESTRAINTS</strong></p><p>
</p><p style="text-align:center"><strong>Regulatory Fragmentation and Compliance Costs to Challenge Market Expansion</strong></p><p>
</p><p>Despite progress in legalization, the cannabis oil market faces significant regulatory hurdles. Varying legal frameworks between countries and even regional jurisdictions create complex compliance requirements. In the U.S. alone, over 20 different state-level regulatory regimes govern cannabis products, with testing standards, labeling rules, and permitted THC limits differing substantially. This fragmentation forces producers to maintain multiple formulations and packaging variants, increasing operational costs by 15-25% compared to conventional consumer goods.</p><p>
</p><p><strong>Other Restraints</strong></p><p>
</p><p><strong>Banking and Financial Limitations</strong></p><p>
Restricted access to financial services remains a systemic barrier, with many global banking institutions refusing to work with cannabis businesses due to federal prohibition in key markets. This forces operators to rely on cash transactions and limits their ability to secure working capital.</p><p>
</p><p><strong>Supply Chain Complexities</strong></p><p>
The legal cannabis sector's emerging infrastructure presents logistical challenges, from seed-to-sale tracking requirements to specialized storage and transportation needs. These factors currently reduce profit margins by 8-12% compared to mature agricultural commodity markets.</p><p>
<strong>MARKET CHALLENGES</strong></p><p>
</p><p style="text-align:center"><strong>Product Standardization and Quality Control to Hinder Market Development</strong></p><p>
</p><p>The lack of uniform testing standards and quality benchmarks presents ongoing challenges for cannabis oil producers. Potency variability between batches remains common, with independent testing revealing cannabinoid concentration deviations up to 40% from labeled amounts in some markets. This inconsistency undermines consumer trust and complicates dosing for medical applications. The industry's relative immaturity means many producers lack the sophisticated analytical equipment and quality systems required for pharmaceutical-grade manufacturing.</p><p>
</p><p><strong>Other Challenges</strong></p><p>
</p><p><strong>Consumer Misinformation</strong></p><p>
Despite growing awareness, many consumers remain confused about cannabinoid effects and proper usage. Over 35% of purchasers in a 2024 survey couldn't accurately differentiate between CBD, THC, and other cannabinoids, leading to improper product selection and disappointing experiences.</p><p>
</p><p><strong>Talent Shortages</strong></p><p>
The industry faces a critical shortage of professionals with dual expertise in cannabis cultivation and pharmaceutical manufacturing. This skills gap is particularly acute in extraction technology and formulation science, where demand for qualified personnel outweighs supply by nearly 4:1 in major markets.</p><p>
<strong>MARKET OPPORTUNITIES</strong></p><p>
</p><p style="text-align:center"><strong>Emerging Markets and Product Innovation to Create Substantial Growth Potential</strong></p><p>
</p><p>Asia-Pacific represents the most significant untapped opportunity, with several countries implementing medical cannabis programs and considering broader legalization. Thailand's 2024 decision to fully legalize cannabis created a $1.2 billion market overnight, while Japan and South Korea are expanding medical access. These developments suggest the region could account for 25% of global cannabis oil demand by 2032, up from just 8% in 2024.</p><p>
</p><p style="text-align:center"><strong>Pharmaceutical Development to Open New Revenue Streams</strong></p><p>
</p><p>Major pharmaceutical companies are increasingly entering the cannabis therapeutics space, with over 60 cannabinoid-based drugs currently in development pipelines. These investments validate cannabis oil's medical potential while creating premium opportunities for producers that can meet Good Manufacturing Practice (GMP) standards. The market for FDA-approved cannabinoid pharmaceuticals is projected to exceed $15 billion by 2032 as more prescription products enter mainstream healthcare.</p><p>

</p><p><strong>â¤ Recent clinical breakthroughs in cannabinoid delivery systems, including water-soluble formulations and nanoemulsions, are overcoming bioavailability challenges and expanding treatment applications.</strong></p><p>
</p><p>Additionally, technological advancements in extraction and purification are enabling higher-margin specialty products. Supercritical CO2 extraction systems now achieve 99%+ purity levels while retaining full-spectrum cannabinoid profiles, creating opportunities in premium medical and wellness segments.</p><p>
</p><p>
<strong>Segment Analysis:</strong></p><p>
<strong>By Type</strong></p><p>
</p><p><strong>Pharmaceutical Grade Segment Leads Owing to Demand for High-Purity Cannabis Oil in Medical Applications</strong></p><p>
</p><p>The market is segmented based on type into:</p><p>
</p><p>Food Grade</p><p>Pharmaceutical Grade</p><p>
<strong>By Application</strong></p><p>
</p><p><strong>Medical Segment Dominates Market Share Due to Increasing Cannabis-Based Therapeutics</strong></p><p>
</p><p>The market is segmented based on application into:</p><p>
</p><p>Nutraceutical</p><p>Food</p><p>Cosmetics</p><p>Medical</p><p>Others</p><p>
<strong>By Sales Channel</strong></p><p>
</p><p><strong>Distribution Channel Segment Holds Major Share with Expanding Retail and E-Commerce Presence</strong></p><p>
</p><p>The market is segmented based on sales channel into:</p><p>
</p><p>Direct Channel</p><p>Distribution Channel</p><p>
</p><p>
<strong>COMPETITIVE LANDSCAPE</strong></p><p>
<strong>Key Industry Players</strong></p><p>
</p><p style="text-align:center"><strong>Companies Invest in Innovation and Expansion Amid Rising Demand for Cannabis Oil</strong></p><p>
</p><p>The global cannabis oil market remains highly competitive, with both established pharmaceutical companies and emerging CBD-focused firms vying for market share. <strong>Aurora Cannabis</strong> and <strong>Canopy Growth Corporation</strong> lead the industry, leveraging their strong distribution networks and vertically integrated supply chains across North America and Europe. These companies accounted for a combined 18% of the pharmaceutical-grade cannabis oil market in 2024.</p><p>
</p><p><strong>CV Sciences</strong> has gained significant traction in the nutraceutical segment, with its PlusCBD Oil products becoming one of North America's top-selling CBD brands. Meanwhile, European players like <strong>ENDOCA</strong> and <strong>PharmaHemp</strong> dominate their regional markets through organic cultivation practices and GMP-certified production facilities, appealing to quality-conscious consumers.</p><p>
</p><p>Strategic acquisitions have become a key growth strategy, with major players expanding their geographical footprint. For instance, Aurora Cannabis recently acquired a Portuguese producer to strengthen its EU presence, while Canopy Growth continues to diversify into the U.S. market through strategic partnerships.</p><p>
</p><p>Smaller, specialized companies such as <strong>Elixinol</strong> and <strong>HemPoland</strong> focus on niche segments like premium organic extracts, differentiating themselves through sustainable farming practices and transparency in sourcing. These firms are increasingly attracting investment from larger players looking to expand their product portfolios.</p><p>
<strong>List of Key Cannabis Oil Companies Profiled</strong></p><p>
</p><p>Aurora Cannabis (Canada)</p><p>Canopy Growth Corporation (Canada)</p><p>CV Sciences (U.S.)</p><p>ENDOCA (Netherlands)</p><p>PharmaHemp (Slovenia)</p><p>BAFA Gmbh (Germany)</p><p>Protect Pharma Rakitovica (Croatia)</p><p>Elixinol (U.S.)</p><p>HemPoland (Poland)</p><p>Gaia Herbs (U.S.)</p><p>ISODIOL (Canada)</p><p>CBD American Shaman (U.S.)</p><p>
</p><p>
<strong>CANNABIS OIL MARKET TRENDS</strong></p><p>
<strong>Medical Legalization and Growing Acceptance to Drive Market Expansion</strong></p><p>
</p><p>The global cannabis oil market is experiencing robust growth, primarily fueled by increasing legalization for medical and recreational use across key regions. As of 2025, over 50 countries have legalized medical cannabis to varying degrees, with North America and Europe leading adoption rates. This regulatory shift has created a favorable environment for product innovation, with pharmaceutical-grade cannabis oil gaining traction for chronic pain management, epilepsy treatment, and anxiety disorders. The market witnessed a <strong>compound annual growth rate (CAGR) of 18.7%</strong> between 2020-2024, and projections suggest this momentum will continue through 2032 as more nations reconsider prohibition policies.</p><p>
<strong>Other Trends</strong></p><p>
</p><p><strong>Premiumization of Nutraceutical Products</strong></p><p>
</p><p>Consumer demand for wellness-oriented cannabis oil products has spurred premiumization in the nutraceutical segment. Manufacturers are increasingly combining CBD and THC oils with functional ingredients like adaptogens, terpenes, and omega fatty acids to create targeted formulations. The global nutraceutical application segment accounted for <strong>38% of total market revenue</strong> in 2024, with sleep aids and stress relief products demonstrating particularly strong sales growth. This trend aligns with broader shifts toward preventive healthcare, where consumers view cannabis oil as a natural alternative to synthetic pharmaceuticals.</p><p>
<strong>Technological Advancements in Extraction Methods</strong></p><p>
</p><p>Innovation in extraction technologies is revolutionizing cannabis oil production efficiency and purity standards. While CO2 extraction remains dominant with <strong>62% market share</strong> in 2024, emerging techniques like ultrasonic and hydrodynamic extraction are gaining ground for their ability to preserve delicate cannabinoids and terpenes. The industry is also witnessing increased adoption of nanoemulsion technology to improve bioavailability, particularly for pharmaceutical applications. These advancements are reducing production costs while enabling more consistent product quality - critical factors as the market moves toward stricter regulatory compliance and standardization.</p><p>

<strong>Regional Analysis: Cannabis Oil Market</strong></p><p>
</p><p><strong>North America</strong></p><p>
The North American cannabis oil market continues to dominate globally, driven by progressive legalization and strong consumer demand. The United States, despite federal restrictions, has seen substantial growth with state-level legalization efforts in 38 states for medical use and 23 for recreational purposes as of 2024. Canada remains a significant player after nationwide legalization in 2018, with Aurora Cannabis and Canopy Growth Corp leading production. The pharmaceutical-grade segment shows particular strength due to expanding medical cannabis applications, while increasing adoption in wellness products fuels the food grade segment. Regulatory complexity and interstate commerce limitations remain challenges, though industry consolidation through M&amp;A activity is accelerating market maturation.</p><p>
</p><p><strong>Europe</strong></p><p>
Europe's cannabis oil market is experiencing steady expansion, characterized by rigid regulatory frameworks and growing therapeutic acceptance. Germany stands as the largest medical cannabis market, with estimated sales exceeding â¬200 million in 2024, while the UK shows accelerating growth following NHS approvals for certain cannabis-based medicines. The EU's Novel Food regulation continues to influence CBD oil distribution, requiring companies like ENDOCA and BAFA Gmbh to navigate complex compliance requirements. Southern European nations are emerging as cultivation hubs due to favorable climates, though market fragmentation persists across the region. Patient accessibility issues and reimbursement policies remain key growth barriers despite increasing physician acceptance of cannabis therapies.</p><p>
</p><p><strong>Asia-Pacific</strong></p><p>
The Asia-Pacific region presents a complex landscape for cannabis oil, combining regulatory conservatism with pockets of rapid growth. Australia and New Zealand lead in medical cannabis adoption, with approved prescriptions growing over 300% since 2020. China maintains strict prohibition despite being the world's largest hemp producer, while Thailand's 2022 cannabis decriminalization has created a booming wellness market. India shows potential through its traditional Ayurvedic cannabis use, though legal ambiguity persists. Japanese consumers demonstrate strong interest in CBD wellness products, creating import opportunities despite THC prohibition. The region's cultural diversity leads to vastly different consumption patterns, with nutraceutical applications gaining more traction than medical uses in most markets.</p><p>
</p><p><strong>South America</strong></p><p>
South America's cannabis oil market is developing unevenly, with Uruguay maintaining its position as the most progressive market following full legalization in 2013. Brazil has emerged as a significant medical cannabis consumer, with registered patients exceeding 50,000 in 2024, though domestic production remains limited. Colombia's focus on low-cost cultivation positions it as an export leader, while Argentina and Chile show gradual regulatory progress. Economic instability and banking restrictions continue hindering market development, along with lingering social stigma. However, growing patient advocacy and expanding domestic manufacturing capabilities suggest long-term growth potential, particularly for affordable pharmaceutical-grade products serving regional healthcare systems.</p><p>
</p><p><strong>Middle East &amp; Africa</strong></p><p>
The MEA region demonstrates cautious progress in cannabis oil acceptance, with Israel at the forefront through its advanced medical cannabis program and export-focused industry. South Africa's constitutional court ruling legalizing private cannabis use has created nascent market opportunities, though commercial frameworks remain underdeveloped. Gulf nations maintain strict prohibitions, except for limited pharmaceutical applications in the UAE. Africa's traditional cannabis cultivation countries like Morocco and Lesotho are developing legal frameworks to capitalize on medicinal export potential. Religious and cultural sensitivities continue limiting domestic consumption growth, though increasing research collaborations suggest gradual attitude shifts. Infrastructure gaps and inconsistent regulatory approaches across countries present challenges for market standardization and scaling.</p><p></p><p><strong>Key Report Takeaways</strong></p><p></p><p>
</p><p>
</p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p>
</p><p>This report presents a comprehensive analysis of the global and regional markets for Cannabis Oil, covering the period from 2024 to 2032. It includes detailed insights into the current market status and outlook across various regions and countries, with specific focus on:</p><p>
</p><p><strong>Sales, sales volume, and revenue forecasts</strong></p><p><strong>Detailed segmentation by type and application</strong></p><p>
</p><p>In addition, the report offers in-depth profiles of key industry players, including:</p><p>
</p><p>Company profiles</p><p>Product specifications</p><p>Production capacity and sales</p><p>Revenue, pricing, gross margins</p><p>Sales performance</p><p>
</p><p>It further examines the competitive landscape, highlighting the major vendors and identifying the critical factors expected to challenge market growth.</p><p>
</p><p>As part of this research, we surveyed Cannabis Oil companies and industry experts. The survey covered various aspects, including:</p><p>
</p><p>Revenue and demand trends</p><p>Product types and recent developments</p><p>Strategic plans and market drivers</p><p>Industry challenges, obstacles, and potential risks</p><p>
<strong>FREQUENTLY ASKED QUESTIONS:</strong></p><p>
<strong>What is the current market size of Global Cannabis Oil Market?</strong></p><p>
</p><p><strong>-&gt;</strong> Global cannabis oil market was valued at USD 2.8 billion in 2024 and is expected to reach USD 12.9 billion by 2032.</p><p>
<strong>Which key companies operate in Global Cannabis Oil Market?</strong></p><p>
</p><p><strong>-&gt; Key players</strong> include <strong>Aurora Cannabis, Canopy Growth Corporation, CV Sciences, ENDOCA, Pharmahemp, Cannavest, and Elixinol</strong>, among others.</p><p>
<strong>What are the key growth drivers?</strong></p><p>
</p><p>-&gt; Key growth drivers include <strong>increasing legalization, rising demand for CBD-based therapeutics, and growing consumer awareness about wellness benefits</strong>.</p><p>
<strong>Which region dominates the market?</strong></p><p>
</p><p><strong>-&gt; North America</strong> currently leads the market, while <strong>Asia-Pacific</strong> shows the highest projected growth rate.</p><p>
<strong>What are the emerging trends?</strong></p><p>
</p><p>-&gt; Emerging trends include <strong>THC-free formulations, nanoemulsion technology for enhanced bioavailability, and integration into functional foods</strong>.</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/233189/cannabis-oil-market">
            https://www.24chemicalresearch.com/reports/233189/cannabis-oil-market</a></b></div><br>
            <b>Table of Content:</b><p>Table of Contents<br />
<br />
Chapter 1 Cannabis Oil Market Overview<br />
    1.1 Cannabis Oil Definition<br />
    1.2 Global Cannabis Oil Market Size Status and Outlook (2017-2031)<br />
    1.3 Global Cannabis Oil Market Size Comparison by Region (2017-2031)<br />
    1.4 Global Cannabis Oil Market Size Comparison by Type (2017-2031)<br />
    1.5 Global Cannabis Oil Market Size Comparison by Application (2017-2031)<br />
    1.6 Global Cannabis Oil Market Size Comparison by Sales Channel (2017-2031)<br />
    1.7 Cannabis Oil Market Dynamics<br />
        1.7.1 Market Drivers/Opportunities<br />
        1.7.2 Market Challenges/Risks<br />
        1.7.3 Market News (Mergers/Acquisitions/Expansion)<br />
        1.7.4 COVID-19 Impacts<br />
        1.7.5 Russia-Ukraine War Impacts<br />
Chapter 2 Cannabis Oil Market Segment Analysis by Player<br />
    2.1 Global Cannabis Oil Sales and Market Share by Player (2020-2022)<br />
    2.2 Global Cannabis Oil Revenue and Market Share by Player (2020-2022)<br />
    2.3 Global Cannabis Oil Average Price by Player (2020-2022)<br />
    2.4 Players Competition Situation & Trends<br />
    2.5 Conclusion of Segment by Player<br />
Chapter 3 Cannabis Oil Market Segment Analysis by Type<br />
    3.1 Global Cannabis Oil Market by Type<br />
        3.1.1 Food Grade<br />
        3.1.2 Pharmaceutical Grade<br />
    3.2 Global Cannabis Oil Sales and Market Share by Type (2017-2022)<br />
    3.3 Global Cannabis Oil Revenue and Market Share by Type (2017-2022)<br />
    3.4 Global Cannabis Oil Average Price by Type (2017-2022)<br />
    3.5 Leading Players of Cannabis Oil </p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/233189/cannabis-oil-market">
            https://www.24chemicalresearch.com/reports/233189/cannabis-oil-market</a></b></div><br>

<b>CONTACT US:</b><br>
            203A, City Vista, Fountain Road, Kharadi, Pune, India - 411014<br>
            International: +1(332) 2424 294<br>
            Asia: +91 9169162030 <br><br>
            Follow Us On LinkedIn: <a href="https://www.linkedin.com/company/24chemicalresearch/">24ChemicalResearch LinkedIn</a>